Board of Directors

John Mastrototaro, PhD, has over 30 years of experience in the medical device industry, leading innovation and bringing new products to the market. Before becoming CEO of Movano Health, he was the COO of Orthosensor, Inc., which was acquired by Stryker (NYSE: SYK). Previously, Mastrototaro spent the majority of his career with Medtronic and MiniMed, where he was instrumental in initiating and leading a series of firsts in the world of diabetes, including the ambulatory continuous glucose monitoring system, the sensor augmented insulin pump and the early generations of the artificial pancreas. During his tenure in Medtronic’s Diabetes division, Mastrototaro held a number of positions, including CTO, VP of R&D and Business Development and Global VP of Clinical Research and Health Affairs. He was also Medtronic’s first VP of Informatics, where he helped develop a corporate strategy for the use of data and analytics to improve healthcare delivery.

Member of the Compensation Committee
Member of the Governance Committee

Rubén Caballero is a proven product and technology innovator and has over 25 years of experience in R&D, prototyping, designing, integrating, testing and shipping millions of world class consumer electronics with wireless technologies. Today, Caballero is Microsoft’s Corporate Vice President of Devices & Technology Engineering for the Mixed Reality Division, where he oversees Mixed Reality, AI and other special projects. Previously, he was the Vice President of Engineering at Apple, and one of the founding leaders of the iPhone hardware design team. His role later expanded to oversee development of the iPad, Apple Watch, Macintosh and other hardware products. Caballero’s senior executive role at Apple provided him with the opportunity to build and scale global teams, including the Wireless Design and Technology team of over 1,000 engineers in 26 countries for all the products and ecosystems at Apple.

Member of the Audit Committee 
Member of the Compensation Committee
Member of the Governance Committee


Brian Cullinan is an accomplished business executive with more than 35 years of experience working for PricewaterhouseCoopers LLP (PwC) until his retirement from the firm in 2020. While at PwC, Cullinan was an Assurance partner advising some of the firm’s most high-profile clients and their Boards and Audit Committees on strategic, financial and operational initiatives. Throughout his career with PwC, Cullinan held various senior leadership positions, including serving on PwC’s US Board for eight years (four years as its Lead Director) and being elected to PwC’s Global Board of Partners. In addition, during his time at PwC, Cullinan served as the firm’s Southwest Region Managing Partner responsible for driving strategy, growth and operations across the firm’s various business lines. Cullinan’s other roles included serving as the firm’s West Region Assurance Leader and as the US leader for the Entertainment, Media & Communications assurance practice.

Chair of the Board
Member of the Audit Committee 
Member of the Compensation Committee
Member of the Governance Committee


Emily Wang Fairbairn is the Chair of the Board at Movano Health. She has spent the majority of her career in executive leadership and management positions and as a seasoned investor and mentor to a variety of startups. She was co-founder and CEO of multi-billion-dollar hedge fund, Ascend Capital, for nearly two decades prior to retiring in 2018. The firm focused on managing assets for institutional clients such as pensions, endowments and public companies. Prior to Ascend Capital, Fairbairn built a successful practice of equity portfolio construction and financial planning for high net worth clients for Merrill Lynch. Today, Fairbairn is an active investor, serving on the funding board of MIT Sandbox Fund to mentor aspiring entrepreneurs, and is an engaged philanthropist with a history of supporting medical research, education and athletics.

Michael Leabman is Movano Health's founder and CTO. An MIT-educated, serial entrepreneur with a passion for envisioning, inventing and executing, Leabman has previously founded four other companies in the wireless space and has more than 200 patents issued in smart antenna array for telecom/power. Leabman has brought a team of seasoned engineers, many of whom have worked with him over the past 23 years, to apply their leading-edge expertise to Movano Health's designs.

Member of the Audit Committee

Dr. Wirk is a leader in healthcare dedicated investment with a track record of success in medicine, partnerships, and research. With over 20 years of investment experience in public and private life science companies, Dr. Wirk is the founder and Chief Investment Officer of Palkon Capital Management, a healthcare dedicated investment firm launched in partnership with Julian Robertson and Tiger Management. Formerly, Dr. Wirk was a senior analyst at Bridger Capital. He is the founder of the advisory firm Blue Cotinga and was an early employee at MercuryMD, which was successfully acquired by the Thomson Corp. He currently serves on several boards and associations including Tvardi Therapeutics and the Duke University School of Medicine's Medical Alumni Council, the leadership group for the Medical Alumni Association. Dr. Wirk completed research training programs in oncology and trauma surgery at the University of Texas MD Anderson Cancer Center, Rabin Medical Center through the National Institutes of Health Fogarty International Center, and Duke University Medical Center. Dr. Wirk earned his M.D., M.B.A., and B.S. degrees from Duke University.